University of Manchester Techbio Spin-Out Secures £5 Million to Deploy Quantum Physics, AI Modelling, and Highly Automated Labs to Power Next Gen Enzyme Engineering
Imperagen, a Manchester-based techbio company using AI and quantum physics to engineer better enzymes faster, has closed a £5 million seed funding round led by PXN Ventures with participation from Imperagen’s existing investors IQ Capital and Northern Gritstone.
